65,437 trials
Crohn's Disease
Primary: Percentage of Participants With Mucosal Healing and No Deep Ulcerations — 30.3; 45.9 percentage of participants — p=0.010
Prolymphocytic Leukemia · Recurrent Adult Hodgkin Lymphoma · Recurrent Childhood Hodgkin Lymphoma
Primary: Engraftment of HLA Identical PBSC Allografts — 53 Participants
Urge Urinary Incontinence · Overactive Bladder
Primary: Change in Urge Urinary Incontinence (UUI) Episodes — -3.13; -3.15; -3.32; -3.25 Mean change in UUI episodes from baselin
Adult Glioblastoma
Primary: Number of Participants Who Received Treatment Recommendations Within 35 Days of Surgery — 15 Participants
Pre-diabetes · Type 2 Diabetes
Primary: Effect on Functional Beta-cell Mass as Determined by Change in ß-cell Secretory Capacity at 6 Months (μU/ml) — 214; 149; 133; 188.5 μU/ml — p==0.1
Type 2 Diabetes · Coronary Heart Disease
Primary: Change in E to A Ratio — 1.04; 1.25 Ratio — p=<0.01
HIV Infections · Alcoholism
Primary: Number of Drinking Days Out of the Past 90 Days — 34.03; 30.45; 13.58; 20.22 days — p=<0.005
Hematopoietic/Lymphoid Cancer
Primary: Functional Assessment of Cancer Treatment - Blood/Marrow Transplant — 97.7; 98.1; 95.7; 95.8 units on a scale — p=.96
Rhinitis, Allergic, Perennial
Primary: Correlations of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q) Preference Module With Treatment Satisfaction Questionnaire for Medicines (TSQM)…
Cardiovascular Disease
Primary: Change in LDL From Baseline to 12 Months — 27.9; 25.1; 33.6; 25.1 mg/dL
Denture Retention
Primary: Combined Mass of Peanuts (Gram) (From Upper and Lower Dentures) for Reference Denture Adhesive and on no Adhesive Use — 0.06; 0.08 gram (g) — p=0.0987
Meningococcal Disease
Primary: Percentages of Subjects Without Bactericidal Activity at 1:4 Dilution Against Each US Neisseria Meningitides (N. Meningitidis) Serogroup B Strain at 1 Month After the…
Liver Transplant
Primary: Infection Rates — 27; 26; 11; 7 Participants — p=0.841
Infection, Human Immunodeficiency Virus
Primary: Change From Baseline in Plasma Human Immunodeficiency Virus (HIV-1) Ribonucleic Acid (RNA) to Day 11 — -2.169; -0.092 log10 copies/mL — p=<0.001
Healthy Adults
Primary: Number of Subjects With Abnormal Lab Values — 1 Participants